Temple Syndrome in a Patient With Variably Methylated CpGs at the Primary MEG3/DLK1:IG-DMR and Severely Hypomethylated CpGs at the Secondary MEG3:TSS-DMR
Clinical Epigenetics - Germany
doi 10.1186/s13148-019-0640-2
Full Text
Open PDFAbstract
Available in full text
Date
March 7, 2019
Authors
Publisher
Springer Science and Business Media LLC